HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirofumi Jono Selected Research

Polyneuropathies (Polyneuropathy)

1/2018Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
11/2016Novel Antibody for the Treatment of Transthyretin Amyloidosis.
1/2016Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
12/2014Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
3/2014Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.
12/2013Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
12/2013Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
4/2013Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
8/2012Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
6/2012Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirofumi Jono Research Topics

Disease

24Neoplasms (Cancer)
01/2020 - 08/2004
24Polyneuropathies (Polyneuropathy)
01/2018 - 02/2008
19Amyloidosis
01/2019 - 02/2008
13Infections
01/2019 - 11/2002
12Squamous Cell Carcinoma of Head and Neck
12/2021 - 09/2009
10Inflammation (Inflammations)
01/2020 - 03/2004
6Acute Kidney Injury (Acute Renal Failure)
02/2021 - 01/2014
6Body Weight (Weight, Body)
09/2020 - 11/2018
6Amyloid Plaque
02/2015 - 09/2011
6Chronic Obstructive Pulmonary Disease (COPD)
12/2008 - 05/2002
5Otitis Media
12/2008 - 05/2002
3Glioma (Gliomas)
04/2022 - 08/2009
3Pneumonia (Pneumonitis)
05/2020 - 05/2010
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 01/2014
3Bacterial Infections (Bacterial Infection)
07/2007 - 03/2004
2Immunoglobulin Light-chain Amyloidosis
11/2021 - 01/2012
2Traumatic Brain Injuries (Traumatic Brain Injury)
09/2021 - 01/2021
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2021 - 05/2010
2Fibrosis (Cirrhosis)
08/2019 - 04/2012
2Transthyretin-Related Hereditary Amyloidosis
01/2019 - 01/2018
2Familial Amyloidosis (Hereditary Amyloidosis)
01/2016 - 03/2014
2Testicular Neoplasms (Testicular Cancer)
01/2015 - 01/2014
2Glioblastoma (Glioblastoma Multiforme)
08/2014 - 08/2009
2Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy)
07/2014 - 12/2013
2Breast Neoplasms (Breast Cancer)
02/2014 - 09/2013
2Carcinogenesis
03/2012 - 08/2004
2Respiratory Tract Diseases (Respiratory Tract Disease)
12/2008 - 01/2008
2Asthma (Bronchial Asthma)
02/2008 - 01/2008
2Cystic Fibrosis (Mucoviscidosis)
02/2008 - 08/2002
1Renal Cell Carcinoma (Grawitz Tumor)
05/2022
1Interstitial Lung Diseases (Interstitial Lung Disease)
05/2022
1Multiple Myeloma
11/2021
1Diarrhea
11/2021
1Hypothermia
09/2021
1Hematoma
09/2021
1Bacteremia
11/2020

Drug/Important Bio-Agent (IBA)

26Prealbumin (Transthyretin)IBA
01/2019 - 02/2008
14Amyloid (Amyloid Fibrils)IBA
01/2019 - 12/2009
11Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2008
8MucinsIBA
05/2009 - 11/2002
7Small Interfering RNA (siRNA)IBA
01/2019 - 08/2009
6CyclodextrinsIBA
01/2019 - 07/2011
6NF-kappa B (NF-kB)IBA
05/2010 - 08/2004
5Cisplatin (Platino)FDA LinkGeneric
12/2021 - 05/2012
5Deubiquitinating EnzymesIBA
01/2020 - 04/2012
5Dendrimers (Dendrons)IBA
01/2019 - 06/2012
5Messenger RNA (mRNA)IBA
06/2016 - 09/2009
5Peptides (Polypeptides)IBA
06/2016 - 08/2013
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2014 - 03/2004
5MidkineIBA
05/2012 - 04/2010
4EnzymesIBA
02/2021 - 01/2014
4IndicanIBA
02/2021 - 01/2014
4Pharmaceutical PreparationsIBA
05/2020 - 05/2012
4AntigensIBA
06/2016 - 08/2013
4EpitopesIBA
06/2016 - 06/2012
4CytokinesIBA
08/2014 - 03/2004
4Transforming Growth Factor beta (TGF-beta)IBA
01/2009 - 11/2002
3Complementary DNA (cDNA)IBA
06/2016 - 01/2014
3Biological ProductsIBA
08/2014 - 09/2009
3Deubiquitinating Enzyme CYLDIBA
02/2014 - 08/2007
3Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2011 - 08/2009
3Interleukin-6 (Interleukin 6)IBA
09/2011 - 08/2009
3tocilizumab (atlizumab)FDA Link
09/2011 - 08/2009
3TNF Receptor-Associated Factor 6 (TRAF6)IBA
10/2007 - 08/2004
3Transcription Factors (Transcription Factor)IBA
10/2007 - 08/2004
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2022 - 01/2010
2Bortezomib (Velcade)FDA Link
11/2021 - 10/2019
2Thiamylal (Surital)FDA Link
09/2021 - 01/2021
2SulfotransferasesIBA
02/2021 - 09/2014
2Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2010
2Anti-Bacterial Agents (Antibiotics)IBA
11/2018 - 07/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2014 - 09/2009
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2014 - 08/2013
2AlbuminsIBA
12/2013 - 08/2011
2AA amyloidosisIBA
01/2012 - 10/2010
2Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2010 - 02/2008
2GlucocorticoidsIBA
12/2008 - 05/2002
1TOR Serine-Threonine KinasesIBA
05/2022
1Ribosomal Proteins (Ribosomal Protein)IBA
04/2022
1Cetuximab (Erbitux)FDA Link
12/2021
1ErbB Receptors (EGF Receptor)IBA
12/2021
1Epidermal Growth Factor (EGF)IBA
12/2021
1LipidsIBA
12/2021
1ClathrinIBA
12/2021
1CholesterolIBA
12/2021
1BarbituratesIBA
09/2021
1barbituric acid (barbiturate)IBA
09/2021
1Sulfates (Sulfates, Inorganic)IBA
02/2021
1Cefazolin (Ancef)FDA LinkGeneric
11/2020
1CefotiamFDA Link
11/2020
1flomoxefIBA
11/2020
1Cefmetazole (Cefmetazole Sodium)FDA Link
11/2020
1Polymethyl Methacrylate (Sol)IBA
09/2020
1Ribosomal Protein S6IBA
06/2020

Therapy/Procedure

21Therapeutics
12/2021 - 02/2008
5Liver Transplantation
01/2016 - 11/2010
2Continuous Renal Replacement Therapy
09/2020 - 01/2019
2Immunotherapy
06/2016 - 01/2015
1Decompression
09/2021
1Craniotomy
09/2021